Avalo Therapeutics Stock Forecast

AVTX's stock price has decreased by -56.08% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 14 analysts polled by S&P Global, Avalo Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $38.5. The average 1-year stock price forecast is 455.56% higher than the current stock price, while the lowest is $10 (+44.30%) and the highest is $60 (+765.80%).

Price Target: $38.5 (+455.56%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$10	$38.5	$38.5	$60
Change	+44.30%	+455.56%	+455.56%	+765.80%

Analyst Ratings

The average analyst rating for Avalo Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	11	12	13	13	12	10
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	14	15	15	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Driscoll Wedbush	Wedbush	Buy Reiterates $34 → $22	Buy	Reiterates	$34 → $22	+217.46%	Oct 23, 2026
Julian Harrison BTIG	BTIG	Buy Maintains $58 → $10	Buy	Maintains	$58 → $10	+44.30%	Oct 23, 2026
Mitchell Kapoor H.C. Wainwright	H.C. Wainwright	Hold Downgrades $30	Hold	Downgrades	$30	+332.90%	Oct 23, 2026
Yatin Suneja Guggenheim	Guggenheim	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Oct 23, 2026
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $60	Buy	Maintains	$60	+765.80%	Oct 1, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 59.00K

-100.00%

from 59.00K

Revenue Next Year

n/a

EPS This Year

-2.73

from -5.84

EPS Next Year

-2.71

from -2.73

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	5.40M	18.05M	1.92M	441.00K	59.00K	-
Revenue Growth	-19.42%	234.40%	-89.34%	-77.08%	-86.62%	-100.00%
Operating Income	-82.13M	-29.94M	-23.44M	-40.87M	-72.93M	-109.82M
Net Income	-84.38M	-41.66M	-31.54M	-35.13M	-78.26M	-111.21M
EPS	-	-	-	-	-5.84	-2.73
Free Cash Flow	-	-	-	-	-51.46M	-82.00M
No. Analysts	-	-	-	-	-	12

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-100.0%
Avg	-100.0%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-2.18
Avg	-2.73
Low	-3.06

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-